Are you visiting this page with your tablet? Then please hold the device in landscape mode. Are you visiting this page with your smartphone? Then please switch to a tablet or desktop device to see all the content.
kreis
Figures
2019
alt text
Who we are

What really matters:
The patient always comes first.

Revenue

All regions contributed
to revenue growth

Operating Income

Year of investment in
home dialysis and growth markets

1 2019 adjusted for the effect of the IFRS 16 implementation, the effects of the NxStage acquisition, expenses for the cost optimization program and the gain related to divestitures of Care Coordination activities; 2018 adjusted for the contribution of Sound Physicians in H1 2018, the gain related to divestitures of Care Coordination activities and the FCPA related charge.

Net income

Targets for 2019 achieved

1Net income attributable to shareholders of Fresenius Medical Care AG & Co. KGaA.

2019 adjusted for the effect of the IFRS 16 implementation, the effects of the NxStage acquisition, expenses for the cost optimization program and the gain related to divestitures of Care Coordination activities; 2018 adjusted for the contribution of Sound Physicians in H1 2018, the gain related to divestitures of Care Coordination activities and the FCPA related charge.

Dividend

23rd consecutive dividend increase

1CAGR = Compound Annual Growth Rate

2Proposal to be approved by the Annual General Meeting on August 27, 2020.

EMPLOYEES

Our employees are the most valuable asset

DIALYSIS TREATMENTS

Dialysis treatment options at a glance

Downloads

For our patients!
Find out more in our latest publications 2019:

Magazine 2019

(pdf 10 MB )

PROFILE 2019

(pdf 985 KB )

FIVE-YEAR SUMMARY

(xlsx 17 KB )

ANNUAL REPORT 2019

(pdf 3 MB )